B. Metzler seel. Sohn & Co. Holding AG Takes $3.28 Million Position in Avantor, Inc. (NYSE:AVTR)

B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR) during the 3rd quarter, HoldingsChannel reports. The institutional investor purchased 126,855 shares of the company’s stock, valued at approximately $3,282,000.

A number of other large investors have also recently added to or reduced their stakes in the business. Versant Capital Management Inc increased its stake in Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after acquiring an additional 1,102 shares during the last quarter. Blue Trust Inc. increased its position in shares of Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after purchasing an additional 1,391 shares during the last quarter. UMB Bank n.a. acquired a new stake in shares of Avantor during the 3rd quarter worth about $49,000. Nisa Investment Advisors LLC raised its holdings in Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after buying an additional 835 shares during the period. Finally, GAMMA Investing LLC lifted its position in Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after buying an additional 1,285 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Trading Up 2.1 %

Shares of NYSE:AVTR opened at $20.14 on Thursday. Avantor, Inc. has a 52 week low of $19.49 and a 52 week high of $28.00. The company’s 50 day moving average is $24.14 and its two-hundred day moving average is $23.91. The company has a market cap of $13.71 billion, a PE ratio of 43.78, a P/E/G ratio of 2.52 and a beta of 1.35. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84.

Insider Activity at Avantor

In related news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

AVTR has been the subject of several research reports. Stifel Nicolaus lifted their target price on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, July 29th. Morgan Stanley lifted their price objective on Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Wells Fargo & Company decreased their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Robert W. Baird dropped their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Finally, Barclays reduced their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, Avantor presently has an average rating of “Moderate Buy” and a consensus price target of $27.57.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.